Cleared Traditional

K970726 - VAPOCIDE

K970726 is an FDA 510(k) clearance for VAPOCIDE, manufactured by Cottrell, Ltd.. The device is a Class 2 General Hospital device with product code MED cleared through the Traditional 510(k) pathway after a 444-day FDA review.

K970726 · Cottrell, Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1998
Decision
444d
Days
Class 2
Risk

K970726 is an FDA 510(k) clearance for the VAPOCIDE. Classified as Sterilant, Medical Devices (product code MED), Class II - Special Controls.

Submitted by Cottrell, Ltd. (North Attleboro, US). The FDA issued a Cleared decision on May 18, 1998 after a review of 444 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.6885 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Cottrell, Ltd. devices

FDA 510(k) Submission Details - K970726

510(k) Number K970726 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 28, 1997
Decision Date May 18, 1998
Days to Decision 444 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
315d slower than avg
Panel avg: 129d · This submission: 444d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MED Device Classification - Class 2, Special Controls

Product Code MED Sterilant, Medical Devices
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.6885
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - MED Sterilant, Medical Devices

All 34
Devices cleared under the same product code (MED) and FDA review panel - the closest regulatory comparables to K970726.
CIDEX OPA SOLUTION
K001381 · Advanced Sterilization Products · May 2000
CIDEX OPA SOLUTION
K991487 · Advanced Sterilization Products · Oct 1999
ENDO-SPOR PLUS / HYPROCIDE
K972708 · Cottrell, Ltd. · Sep 1999
SPOROX
K970230 · Reckitt Benckiser, Inc. · Oct 1997
PERACT 20 LIQUID STERILANT
K960513 · Minntech Corp. · Oct 1997
WAVICIDE MONITOR STRIPS
K932047 · Serim Research Corp. · Jun 1994